Chair, Department of Chemical Physiology, The Scripps Research Institute; Co-director, Center for Physiological Proteomics, The Scripps Research Institute
President & CEO, Indiana Biosciences Research Institute
Co-Founder and CEO, DNAnexus
Founder and CEO of Brooks Bell Inc.
The past decade has seen tremendous progress in the use of genome technologies for the detection and interpretation of complex biological processes and for understanding the molecular basis of disease. These developments are enabling new approaches to the diagnosis and treatment of a wide array of pathologic conditions. This mini-conference is co-located with the 2014 BIO International Convention, and is presented by the journal Nature, Nature Biotechnology, and the Guangzhou Institutes of Biomedicine & Health, in collaboration with Janssen Labs. More information and online registration is here.